| Trouble mounts for Sanofi dengue vaccine over safety concerns | | | (Reuters) - The World Health Organization said on Monday it hopes to review safety data on Sanofi's dengue vaccine this month, while the Philippines ordered an investigation of its now suspended massive immunization program after the French drugmaker said it could actually worsen the disease in some cases. |
| |
| Montana sues OxyContin maker Purdue over opioid epidemic | | | (Reuters) - Montana has sued OxyContin maker Purdue Pharma LP, withdrawing from a multistate investigation by attorneys general into opioid manufacturers' marketing practices and joining a growing list of states that have broken off to pursue individual lawsuits. |
| |
| Trial results of Zika vaccine Sanofi dropped show promise | | | CHICAGO (Reuters) - A Zika vaccine Sanofi SA dropped in September under political pressure over pricing produced strong responses in more than 90 percent of those taking part in an early-stage clinical trial, U.S. researchers reported on Monday. |
| |
| Court-mandated opioid rehab rarely meets medical standards | | | (Reuters Health) - Fewer than one in 20 people with opioid addiction problems who are ordered into rehab programs by the courts receive methadone or buprenorphine, two drugs doctors consider the best treatment option, a U.S. study suggests. |
| |
| Brazil recommends restrictions on Sanofi dengue vaccine | | | BRASILIA (Reuters) - The Brazilian government said on Monday it has suggested restrictions on the use of a dengue vaccine that has been suspended elsewhere after French drug company Sanofi SA said it could worsen the disease in some cases. |
| |
| Cholera could resurge in Yemen due to lack of aid, fuel: WHO | | | GENEVA (Reuters) - Another wave of cholera could strike Yemen, where a Saudi-led coalition blockade has cut off fuel for hospitals, water pumps and vital aid supplies for starving children, the World Health Organization (WHO) said on Sunday. |
| |
| | |
